McKesson Corporation

From Accountable Brands
Revision as of 02:47, 8 May 2024 by Admin (talk | contribs) (1 revision imported)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


McKesson Corporation


Industry Healthcare
Sub-Brands RexallHealth MartUniprix
Products Pharmaceuticals • Medical technology • Health care services


McKesson Corporation
Formerly
  • Olcott (1828–1833)
  • Olcott & McKesson (1833–1853)
  • McKesson & Robbins (1853–1967)
  • McKessonHBOC (1999–2001)
Company typePublic
IndustryHealthcare
FoundedNew York City, U.S.
1833; 191 years ago (1833)
Founders
Headquarters,
U.S.
Key people
Brian S. Tyler (CEO)
Products
RevenueIncrease US$308.9 billion (2024)
Decrease US$3.909 billion (2024)
Decrease US$3.002 billion (2024)
Total assetsIncrease US$67.44 billion (2024)
Total equityDecrease US$−1.97 billion (2024)
Number of employees
c. 51,000 (2024)
Subsidiaries
WebsiteMcKesson.com
Footnotes / references
Financials as of March 31, 2024.[1]

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSEMCK.

McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags.[2] The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.[3]

Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the United States of America Government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses across the United States.[4][5]

  1. ^ "FY 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 8, 2024. pp. 9, 60, 62.
  2. ^ Mitchell, Luke (February 1, 2009). "Sick in the Head". Harper's Magazine. Archived from the original on May 25, 2017. Retrieved April 24, 2017.
  3. ^ Leggate, James (July 22, 2020). "What is McKesson?". FOXBusiness. Retrieved May 6, 2021.
  4. ^ Terry, Mark. "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 10 December 2021.
  5. ^ "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson Investor Relations. Retrieved May 5, 2021.




Reports